News Column

An Application for the Trademark "PERSONALIZED POSSIBILITIES" Has Been Filed by Abbott Laboratories

August 4, 2014



By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "PERSONALIZED POSSIBILITIES" by Michele H. Bowman, representing Abbott Laboratories. This application was made available to the public on July 22, 2014 (see also Pharmaceutical Companies).

The serial number for this application is 85925624.

The international trademark goods and services class codes for this trademark application are 035, 042 and 044.

As submitted by the applicant, this trademark application relates to the following goods and services:

Promoting pharmacogenomics, molecular diagnostics and companion diagnostics goods and services of others; consulting regarding regulatory matters, namely, clinical data and regulatory submission management and strategic counseling related to clinical testing, review and approval of diagnostic tests paired with specific therapies, in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics; retail store and wholesale store services featuring diagnostic test kits; retail store and wholesale store services featuring diagnostic reagents; retail store and wholesale store services featuring diagnostic kits composed of DNA probes, reagents and antibodies; retail store and wholesale store services featuring test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; retail store and wholesale store services featuring test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; retail store and wholesale store services featuring computer software and hardware in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics;

Scientific and technological research and development services in the areas of pharmacogenomics, molecular diagnostics and companion diagnostics; development of companion diagnostics; Pharmacogenomics research services, namely, biomarker discovery services; molecular diagnostic research services; companion diagnostics research and development of medical tests for diagnosis and treatment; providing information relating to pharmacogenomics, molecular diagnostics and companion diagnostics for research purposes; providing a website featuring information in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for research purposes; consulting in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for research purposes;

Pharmacogenomics services, namely, medical testing for diagnostic or treatment purposes; molecular diagnostics services, namely, medical testing for diagnostic or treatment purposes; companion diagnostics services, namely, medical testing for diagnostic or treatment purposes and managing patient medical testing, namely, medical diagnostic testing monitoring and reporting services; providing information relating to pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposes; providing a website featuring information in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposes; consulting in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposes.

The owner/registrar information for this application is: Michele H. Bowman, Abbott Laboratories, 100 Abbott Park Rd, Abbott Park, IL 60064-6008.

Keywords for this news article include: Pharmaceutical Companies, Trademarks, Abbott Laboratories.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Pharma Business Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters